Pharma News

Researchers find out in a recent study that omalizumab provides benefit to patients with moderate to severe allergic asthma, regardless of body mass index.

Bharat Biotech is in the process of bringing out a vaccine against tuberculosis and soon the firm will sign a MoU with another firm for technology.

"Our honourable Prime Minister has got an agenda of 2025 for the eradication of tuberculosis. I think we are in that direction. But we don't have the technology so we are partnering with somebody else. On that matter we should be announcing soon," Krishna Ella, Chairman and Managing Director said in BioAsia 2022.

Kolkata-based TABLT Pharmacy has raised USD 1.5 million in pre-series A round from investors like JITO Angel Network, Tech Innovation, Lets Venture, Seeders Syndicate, Angel Bay and other angel investors. Also, the founders have themselves participated in this round.

Tablt online pharmacy is launched in 2018 and it is dealing in medicines, OTCs and other healthcare products.

Several FDA-approved drugs including for type 2 diabetes, hepatitis C and HIV significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. Specifically, the team found that these drugs inhibit certain viral enzymes, called proteases, that are essential for SARS-CoV-2 replication in infected human cells.

Biocon Biologics Ltd., a subsidiary of Biocon Ltd announced today that it has entered into a definitive agreement with its partner Viatris Inc.  . Accordingly, Biocon Biologics Ltd will acquire Viatris’ biosimilars business to create a unique fully integrated global biosimilars enterprise. Viatris will receive consideration of up to USD 3.335 billion, including cash up to USD 2.335 billion and Compulsorily Convertible Preference Shares  in BBL, valued at USD 1 billion.

PHD Chamber organized a technical session on Incentive and Schemes offered by Ministry of AYUSH, Govt. of India for ASU Sector on 24th February 2022 during AYUSH e-Mela.

PHD Chamber in collaboration with Ministry of AYUSH, Govt. of India is organizing AYUSH E-Mela Virtual Conference cum Expo 2021 from 24th-26th February 2022.

Pharmacy Council of India has mandated exit exam for D.Pharm candidates to register as pharmacist under section 12 of the Pharmacy Act, 1948. No person shall be registered as a Diploma in Pharmacy Exit Examination candidate unless he has passed Diploma in Pharmacy course from an institution approved by the PCI.

A large number of Indian made medicinal products illegally imported in Switzerland were seized by Swissmedic and the Federal Office for Customs and Border Security. These contained COVID-19 medicines like ivermectin, hydroxychloroquine or antibiotics and erectile stimulants from India.

Swiss government agency along with customs had secured 9,421 packages containing illegally imported medicinal products during 2021. This is a significant increase on the previous year, when there were 6,733 such packages.